1. Atroshi I, Gummesson C, Johnsson R, Ornstein E,
Ranstam J, Rosen I. Prevalence of carpal tunnel
syndrome in a general population. JAMA. 1999;
282(2):153-8.
2. Tuppin P, Blotiere PO, Weill A, Ricordeau P, Allemand
H. [Carpal tunnel syndrome surgery in France in
2008: patients’ characteristics and management]. Rev
Neurol (Paris). 2011; 167(12):905-15.
3. Chammas M, Boretto J, Burmann LM, Ramos RM, Dos
Santos Neto FC, Silva JB. Carpal tunnel syndrome -
Part I (anatomy, physiology, etiology and diagnosis).
Rev Bras Ortop. 2014; 49(5):429-36.
4. Emara MK, Saadah AM. The carpal tunnel syndrome
in hypertensive patients treated with beta-blockers.
Postgrad Med J. 1988; 64(749):191-2.
5. Sestak I, Sapunar F, Cuzick J. Aromatase inhibitorinduced
carpal tunnel syndrome: results from the
ATAC trial. J Clin Oncol. 2009; 27(30):4961-5.
6. Dellon AL, Swier P, Maloney CT Jr, Livengood MS,
Werter S. Chemotherapy-induced neuropathy:
treatment by decompression of peripheral nerves.
Plast Reconstr Surg. 2004; 114(2):478-83.
7. Law HZ, Amirlak B, Cheng J, Sammer DM. An
Association between Carpal Tunnel Syndrome and
Migraine Headaches-National Health Interview
Survey, 2010. Plast Reconstr Surg Glob Open. 2015;
3(3):e333-41.
8. Concannon MJ, Gainor B, Petroski GF, Puckett CL.
The predictive value of electrodiagnostic studies in
carpal tunnel syndrome. Plast Reconstr Surg. 1997;
100(6):1452-8.
9. Pulman J, Jette N, Dykeman J, Hemming K, Hutton JL,
Marson AG. Topiramate add-on for drug-resistant
partial epilepsy. Cochrane Database Syst Rev. 2014;
25(2):CD001417.
10. Lainez MJ, Freitag FG, Pfeil J, Ascher S, Olson WH,
Schwalen S. Time course of adverse events most
commonly associated with topiramate for migraine
prevention. Eur J Neurol. 2007; 14(8):900-6.
11. Privitera MD, Brodie MJ, Mattson RH, Chadwick DW,
Neto W, Wang S, et al. Topiramate, carbamazepine and
valproate monotherapy: double-blind comparison in
newly diagnosed epilepsy. Acta Neurol Scand. 2003;
107(3):165-75.
12. Young WB, Hopkins MM, Shechter AL, Silberstein
SD. Topiramate: a case series study in migraine
prophylaxis. Cephalalgia. 2002; 22(8):659-63.
13. Bray GA, Hollander P, Klein S, Kushner R, Levy B,
Fitchet M, et al. A 6-month randomized, placebocontrolled,
dose-ranging trial of topiramate for weight
loss in obesity. Obes Res. 2003; 11(6):722-33.
14. Majkowski J, Neto W, Wapenaar R, Van Oene J. Time
course of adverse events in patients with localizationrelated
epilepsy receiving topiramate added to
carbamazepine. Epilepsia. 2005; 46(5):648-53.
)